Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice
Science Advances · 2026
DOI: 10.1126/sciadv.aeb2571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Loretta Dorstyn und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Biology, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia. Hauptthemen laut MEDLINE: Caspase 2, Polyploidy, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Hepatocyte polyploidization promotes liver homeostasis by enhancing resistance to cellular stress. Caspase-2, a proapoptotic protease, restricts polyploidization by deleting polyploid and aneuploid cells. While caspase-2 protects against diet-induced hepatic injury, it also acts as a tumor suppressor by controlling genomic instability and oxidative stress. To investigate these roles, we assessed hepatic ploidy dynamics, liver damage, and age-associated tumorigenesis in caspase-2–deficient and catalytically inactive mutant mice. We found that caspase-2 loss promotes early-onset hepatocyte hyperpolyploidy, accompanied by progressive liver inflammation, fibrosis, oxidative liver damage, ferroptosis, and higher incidence of spontaneous hepatocellular carcinoma in aged animals. Proteomic profiling revealed a pathogenic polyploidy–associated signature associated with caspase-2 deficiency and increased predisposition to liver disease and malignancy. These findings establish caspase-2 enzymatic activity as a critical regulator of hepatic genome stability and preventing age-related liver cancer that strongly argue against therapeutic caspase-2 inhibition as a strategy for managing liver injury or cancer risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Cancer Biology, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia.
- College of Health, Adelaide University, Adelaide, SA 5005, Australia.
- Monash Institute of Pharmaceutical Sciences, Monash University, 399 Royal Parade, Parkville, VIC 3052, Australia.
- Adelaide Medical School, The University of Adelaide, North Terrace, Adelaide, SA 5005, Australia.
- Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
- Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.
ORCID-Profile: Loretta Dorstyn, Yoon Lim, Jack Scanlan, Dylan De Bellis, Michael Katschner, Samantha Emery-Corbin, Jumana Yousef, Laura F Dagley, Chung H Kok, Sonia S Shah, Chiaki Takahashi, Mark A Febbraio, Sharad Kumar
Förderung
- National Health and Medical Research Council
Zitieren
APA
Dorstyn, L., Lim, Y., Scanlan, J., McLennan, E., De Bellis, D., Katschner, M., Finnie, J., Emery-Corbin, S., Yousef, J., Dagley, L. F., Kok, C. H., Shah, S. S., Takahashi, C., Febbraio, M. A., & Kumar, S. (2026). Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice. Science Advances. https://doi.org/10.1126/sciadv.aeb2571
Vancouver
Dorstyn L, Lim Y, Scanlan J, McLennan E, De Bellis D, Katschner M, et al. Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice. Science Advances. 2026. doi:10.1126/sciadv.aeb2571
BibTeX
@article{Dorstyn2026,
author = {Dorstyn, Loretta and Lim, Yoon and Scanlan, Jack and McLennan, Emma and De Bellis, Dylan and Katschner, Michael and Finnie, John and Emery-Corbin, Samantha and Yousef, Jumana and Dagley, Laura F and Kok, Chung H and Shah, Sonia S and Takahashi, Chiaki and Febbraio, Mark A and Kumar, Sharad},
title = {Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeb2571}
}
EUVIMED